Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

BLISS GVS PHARMA LTD. - 506197 - Outcome Of Board Meeting Held On Thursday, January 21, 2021

 We would like to inform you that, Board Meeting of the Company was held today i.e. on Thursday, January 21, 2021 at the registered office of the Company. In pursuant to regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board has considered and approved the following matters amongst others: 1. The Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended December 31, 2020. 2. Appointment of Mr. Gagan Harsh Sharma (DIN: 07939421) as an Additional Director (Executive Director) of the Company w.e.f. January 21, 2021.
21-01-2021
Bigul

BLISS GVS PHARMA LTD. - 506197 - Shareholding for the Period Ended December 31, 2020

 Bliss GVS Pharma Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2020. For more details, kindly Click here
16-01-2021
Bigul

BLISS GVS PHARMA LTD. - 506197 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Please find enclosed herewith a certificate received from Universal Capital Securities Private Limited, Registrar and Share Transfer Agent of the Company under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 for the quarter ended December 31, 2020.
15-01-2021
Bigul

BLISS GVS PHARMA LTD. - 506197 - Statement Of Investor Complaints For The Quarter Ended December 2020

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0220 Name of the Signatory :- Aditi BhattDesignation :- Company Secretary and Compliance Officer
15-01-2021
Bigul

BLISS GVS PHARMA LTD. - 506197 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Please find enclosed herewith the copy of the newspaper advertisement of notice of Board Meeting of the Company scheduled to be held on Thursday, January 21, 2021 at the registered office of the Company, inter-alia, to consider and approve the Un-audited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31, 2020 published in 'The Economic Times & The Free Press Journal' an English Daily and 'Maharashtra Times & Navshakti' a Regional Daily, on January 13, 2021.
15-01-2021
Bigul

BLISS GVS PHARMA LTD. - 506197 - Announcement under Regulation 30 (LODR)-Credit Rating

 Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 09, 2015, We wish to inform you that, Informerics Ratings vide its press releases dated October 26, 2020 and December 18, 2020 respectively has assigned and/or reaffirmed the ratings for the instruments of the Company.
13-01-2021
Bigul

BLISS GVS PHARMA LTD. - 506197 - Board Meeting Intimation for Unaudited Standalone & Consolidated Financial Results Of The Company For The Quarter And Nine Months Ended December 31, 2020

 BLISS GVS PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/01/2021 ,inter alia, to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that a meeting of the Board of Directors of the Company will be held on Thursday, January 21, 2021 at the registered office of the Company to consider and approve, inter alia, the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31, 2020.
13-01-2021
Bigul

BLISS GVS PHARMA LTD. - 506197 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that Registrar and Share Transfer Agent of Company M/s. Universal Capital Securities Private Limited has received request for issue of duplicate share certificates consequent to loss of share certificates from the shareholder.
04-01-2021
Bigul

BLISS GVS PHARMA LTD. - 506197 - Closure of Trading Window

 This is to inform you that pursuant to Securities Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 (including any statutory modification(s) or re-enactment(s) thereof, for the time being in force) and in accordance with the Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Designated Persons, the Trading window for dealing in securities/shares of Bliss GVS Pharma Limited ('the Company') will remain closed for all the Designated Persons and their immediate relatives of the Company with effect from Friday, January 01, 2021 until 48 hours after the announcement of the unaudited financial results of the Company for the quarter and nine months ended December 31, 2020. Accordingly, all Designated Persons and their immediate relatives are advised not to trade (buy or sell or pledge etc.) in the securities/shares of the Company during the aforesaid period of closure of Trading Window.
29-12-2020
Bigul

BLISS GVS PHARMA LTD. - 506197 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that Registrar and Share Transfer Agent of Company M/s. Universal Capital Securities Private Limited has received request for issue of duplicate share certificates consequent to loss of share certificates from the following shareholders.
24-12-2020
Next Page
Close

Let's Open Free Demat Account